

| 货号 | AV064518 |
|---|---|
| 品牌 | abinScience |
| 描述 |
Anti-Omalizumab Neutralizing Antibody ELISA kit (AV064518) — Quantitative sandwich ELISA for Anti-Omalizumab Neutralizing Antibody. Sample: Plasma, Serum. Range: 156.25 - 10, 000 ng/mL. Sensitivity: 82.6 ng/mL.
Highlights
|
| 样本类型 | Plasma, Serum |
| 灵敏度 | 82.6 ng/mL |
| 检测范围 | 156.25 - 10, 000 ng/mL |
| Accession号 | CAS: 242138-07-4 |
| 应用 | ELISA |
| 检测方法 | Colorimetric |
| 实验类型 | Quantitative |
| 回收率 | 80-120% |
| 运输 | 2-8 ℃ |
| 稳定性和存储 | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃. |
| 规格 | Omalizumab |
| 别名 | IGE25, olizumab, pSVIE26, rhuMab-E25, 242138-07-4 |
| 背景 | Immunoglobulin heavy constant epsilon (Omalizumab) is a ~59 kDa protein. Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. 1. Schroeder, HW. et al. (2010) The Journal of allergy and clinical immunology 125, S41-52. PMID: 20176268 2. McHeyzer-Williams, M. et al. (2011) Nature reviews. Immunology 12, 24-34. PMID: 22158414 3. Teng, G. et al. (2007) Annual review of genetics 41, 107-20. PMID: 17576170 |
| Note | For Research Use Only. |

24小时产品查询

扫一扫关注我们

专属渠道经理